| [1] | SUNG H, FERLAY J , SIEGEL R L ,et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin ,2021 ,71 (3):209-249. DOI:10.3322/caac.21660 . | 
																													
																						| [2] | ISIK B, GONULTAS F , SAHIN T ,et al. Microvascular venous invasion in hepatocellular carcinoma:why do recurrences occur?[J]. J Gastrointest Cancer ,2020 ,51 (4):1133-1136. DOI:10.1007/s12029-020-00487-9 . | 
																													
																						| [3] |  | 
																													
																						| [4] | YANG P H, SI A F , YANG J ,et al. A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion[J]. Surgery ,2019 ,165 (4):721-730. DOI:10.1016/j.surg.2018.09.016 . | 
																													
																						| [5] | ZHANG W H, LIU Z K , CHEN J L ,et al. A preoperative model for predicting microvascular invasion and assisting in prognostic stratification in liver transplantation for HCC regarding empirical criteria[J]. Transl Oncol ,2021 ,14 (11):101200. DOI:10.1016/j.tranon.2021.101200 . | 
																													
																						| [6] | LEI Z Q, LI J , WU D ,et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria[J]. JAMA Surg ,2016 ,151 (4):356-363. DOI:10.1001/jamasurg.2015.4257 . | 
																													
																						| [7] | MIZEJEWSKI G J. Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary[J]. J Hepatocell Carcinoma ,2016 ,3 :37-40. DOI:10.2147/JHC.S114198 . | 
																													
																						| [8] |  | 
																													
																						| [9] | NITTA H, ALLARD M A , SEBAGH M ,et al. Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation[J]. Surgery ,2019 ,165 (6):1168-1175. DOI:10.1016/j.surg.2019.01.012 . | 
																													
																						| [10] | WU Y F, TU C Y , SHAO C X . The value of preoperative systemic immune-inflammation index in predicting vascular invasion of hepatocellular carcinoma:a meta-analysis[J]. Rev Bras De Pesquisas Med E Biol ,2021 ,54 (4):e10273. DOI:10.1590/1414-431X202010273 . | 
																													
																						| [11] | SZCZERBA B M, CASTRO-GINER F , VETTER M ,et al. Neutrophils escort circulating tumour cells to enable cell cycle progression[J]. Nature ,2019 ,566 (7745):553-557. DOI:10.1038/s41586-019-0915-y . | 
																													
																						| [12] |  | 
																													
																						| [13] | WANG L, JIN Y X , JI Y Z ,et al. Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma[J]. World J Gastroenterol ,2020 ,26 (14):1647-1659. DOI:10.3748/wjg.v26.i14.1647 . | 
																													
																						| [14] | ZHOU K, GAO C F , ZHAO Y P ,et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B[J]. J Gastroenterol Hepatol ,2010 ,25 (9):1569-1577. DOI:10.1111/j.1440-1746.2010.06383.x . | 
																													
																						| [15] | YAVUZ B G, PESTANA R C , ABUGABAL Y I ,et al. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma[J]. Oncotarget ,2020 ,11 (13):1186-1201. DOI:10.18632/oncotarget.27532 . | 
																													
																						| [16] | O'ROURKE J M, SAGAR V M , SHAH T ,et al. Carcinogenesis on the background of liver fibrosis:implications for the management of hepatocellular cancer[J]. World J Gastroenterol ,2018 ,24 (39):4436-4447. DOI:10.3748/wjg.v24.i39.4436 . | 
																													
																						| [17] | GIRÓN-GONZÁLEZ J A, MARTÍNEZ-SIERRA C , RODRIGUEZ-RAMOS C ,et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis[J]. Liver Int ,2004 ,24 (5):437-445. DOI:10.1111/j.1478-3231.2004.0951.x . | 
																													
																						| [18] |  | 
																													
																						| [19] | ZHANG L X, LV Y , XU A M ,et al. The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma[J]. BMC Cancer ,2019 ,19 (1):841. DOI:10.1186/s12885-019-6011-8 . | 
																													
																						| [20] | TEIJEIRA A, GARASA S , GATO M ,et al. CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity[J]. Immunity ,2020 ,52 (5):856-871. DOI:10.1016/j.immuni.2020.03.001 . | 
																													
																						| [21] |  |